Transcatheter occlusion of antegrade pulmonary flow in children after cavopulmonary anastomosis

Alejandro Torres, Robert Gray, Robert H. Pass

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective: To report our experience with transcatheter occlusion of antegrade pulmonary blood flow (APF) for postoperative complications of cavopulmonary anastomosis (BCPA). Background: It has been suggested that limited APF enhances pulmonary arterial growth in patients undergoing BCPA. However, APF may result in suboptimal postoperative hemodynamics and sequelae such as SVC syndrome or prolonged chest tube drainage. For this subgroup, closure of APF may alleviate these problems. Methods: All BCPA procedures where APF was left open from 1995-2005 were reviewed. Symptomatic patients with APF who underwent a cardiac catheterization in the postoperative period comprised the study cohort. Results: 179 BCPA procedures were performed during the study period. APF was left patent in 29/179. 6/29 patients (age 10-28 months, median 14 months) presented 12 to 130 day; (median 31 days) with persistent pleural effusions (5) or SVC syndrome (1, Five had a history of a previous pulmonary arterial band (PAB) and one pulmonary stenosis. PA pressure was elevated in all (range 17-27 mmHg; median 22 mmHg). Hemodynamic evaluation with temporary APF occlusion was repeated in all patients. APF was successfully closed in 4/6 patients. The Amplatzer POA occluder was used in 3 and the Amplatzer ASD occluder in 1. Pulmonary effusions resolved in all the patients who had transcatheter APF closure as did the case of SVC syndrome. There were no complications. Conclusion: Transcatheter APF occlusion seems both safe and feasible in patients with hemodynamic compromise following BCPA with residual APF. Temporary occlusion testing prior to permanent device closure is recommended.

Original languageEnglish (US)
Pages (from-to)988-993
Number of pages6
JournalCatheterization and Cardiovascular Interventions
Volume72
Issue number7
DOIs
StatePublished - 2008
Externally publishedYes

Fingerprint

Right Heart Bypass
Lung
Septal Occluder Device
Hemodynamics
Chest Tubes
Pulmonary Valve Stenosis

Keywords

  • Antegrade pulmonary flow
  • Catheterization
  • Device occlusion
  • Single ventricle

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Transcatheter occlusion of antegrade pulmonary flow in children after cavopulmonary anastomosis. / Torres, Alejandro; Gray, Robert; Pass, Robert H.

In: Catheterization and Cardiovascular Interventions, Vol. 72, No. 7, 2008, p. 988-993.

Research output: Contribution to journalArticle

Torres, Alejandro ; Gray, Robert ; Pass, Robert H. / Transcatheter occlusion of antegrade pulmonary flow in children after cavopulmonary anastomosis. In: Catheterization and Cardiovascular Interventions. 2008 ; Vol. 72, No. 7. pp. 988-993.
@article{914d5972b7d34e37bf56efa1b1de6cf6,
title = "Transcatheter occlusion of antegrade pulmonary flow in children after cavopulmonary anastomosis",
abstract = "Objective: To report our experience with transcatheter occlusion of antegrade pulmonary blood flow (APF) for postoperative complications of cavopulmonary anastomosis (BCPA). Background: It has been suggested that limited APF enhances pulmonary arterial growth in patients undergoing BCPA. However, APF may result in suboptimal postoperative hemodynamics and sequelae such as SVC syndrome or prolonged chest tube drainage. For this subgroup, closure of APF may alleviate these problems. Methods: All BCPA procedures where APF was left open from 1995-2005 were reviewed. Symptomatic patients with APF who underwent a cardiac catheterization in the postoperative period comprised the study cohort. Results: 179 BCPA procedures were performed during the study period. APF was left patent in 29/179. 6/29 patients (age 10-28 months, median 14 months) presented 12 to 130 day; (median 31 days) with persistent pleural effusions (5) or SVC syndrome (1, Five had a history of a previous pulmonary arterial band (PAB) and one pulmonary stenosis. PA pressure was elevated in all (range 17-27 mmHg; median 22 mmHg). Hemodynamic evaluation with temporary APF occlusion was repeated in all patients. APF was successfully closed in 4/6 patients. The Amplatzer POA occluder was used in 3 and the Amplatzer ASD occluder in 1. Pulmonary effusions resolved in all the patients who had transcatheter APF closure as did the case of SVC syndrome. There were no complications. Conclusion: Transcatheter APF occlusion seems both safe and feasible in patients with hemodynamic compromise following BCPA with residual APF. Temporary occlusion testing prior to permanent device closure is recommended.",
keywords = "Antegrade pulmonary flow, Catheterization, Device occlusion, Single ventricle",
author = "Alejandro Torres and Robert Gray and Pass, {Robert H.}",
year = "2008",
doi = "10.1002/ccd.21748",
language = "English (US)",
volume = "72",
pages = "988--993",
journal = "Catheterization and Cardiovascular Interventions",
issn = "1522-1946",
publisher = "Wiley-Liss Inc.",
number = "7",

}

TY - JOUR

T1 - Transcatheter occlusion of antegrade pulmonary flow in children after cavopulmonary anastomosis

AU - Torres, Alejandro

AU - Gray, Robert

AU - Pass, Robert H.

PY - 2008

Y1 - 2008

N2 - Objective: To report our experience with transcatheter occlusion of antegrade pulmonary blood flow (APF) for postoperative complications of cavopulmonary anastomosis (BCPA). Background: It has been suggested that limited APF enhances pulmonary arterial growth in patients undergoing BCPA. However, APF may result in suboptimal postoperative hemodynamics and sequelae such as SVC syndrome or prolonged chest tube drainage. For this subgroup, closure of APF may alleviate these problems. Methods: All BCPA procedures where APF was left open from 1995-2005 were reviewed. Symptomatic patients with APF who underwent a cardiac catheterization in the postoperative period comprised the study cohort. Results: 179 BCPA procedures were performed during the study period. APF was left patent in 29/179. 6/29 patients (age 10-28 months, median 14 months) presented 12 to 130 day; (median 31 days) with persistent pleural effusions (5) or SVC syndrome (1, Five had a history of a previous pulmonary arterial band (PAB) and one pulmonary stenosis. PA pressure was elevated in all (range 17-27 mmHg; median 22 mmHg). Hemodynamic evaluation with temporary APF occlusion was repeated in all patients. APF was successfully closed in 4/6 patients. The Amplatzer POA occluder was used in 3 and the Amplatzer ASD occluder in 1. Pulmonary effusions resolved in all the patients who had transcatheter APF closure as did the case of SVC syndrome. There were no complications. Conclusion: Transcatheter APF occlusion seems both safe and feasible in patients with hemodynamic compromise following BCPA with residual APF. Temporary occlusion testing prior to permanent device closure is recommended.

AB - Objective: To report our experience with transcatheter occlusion of antegrade pulmonary blood flow (APF) for postoperative complications of cavopulmonary anastomosis (BCPA). Background: It has been suggested that limited APF enhances pulmonary arterial growth in patients undergoing BCPA. However, APF may result in suboptimal postoperative hemodynamics and sequelae such as SVC syndrome or prolonged chest tube drainage. For this subgroup, closure of APF may alleviate these problems. Methods: All BCPA procedures where APF was left open from 1995-2005 were reviewed. Symptomatic patients with APF who underwent a cardiac catheterization in the postoperative period comprised the study cohort. Results: 179 BCPA procedures were performed during the study period. APF was left patent in 29/179. 6/29 patients (age 10-28 months, median 14 months) presented 12 to 130 day; (median 31 days) with persistent pleural effusions (5) or SVC syndrome (1, Five had a history of a previous pulmonary arterial band (PAB) and one pulmonary stenosis. PA pressure was elevated in all (range 17-27 mmHg; median 22 mmHg). Hemodynamic evaluation with temporary APF occlusion was repeated in all patients. APF was successfully closed in 4/6 patients. The Amplatzer POA occluder was used in 3 and the Amplatzer ASD occluder in 1. Pulmonary effusions resolved in all the patients who had transcatheter APF closure as did the case of SVC syndrome. There were no complications. Conclusion: Transcatheter APF occlusion seems both safe and feasible in patients with hemodynamic compromise following BCPA with residual APF. Temporary occlusion testing prior to permanent device closure is recommended.

KW - Antegrade pulmonary flow

KW - Catheterization

KW - Device occlusion

KW - Single ventricle

UR - http://www.scopus.com/inward/record.url?scp=60749129573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60749129573&partnerID=8YFLogxK

U2 - 10.1002/ccd.21748

DO - 10.1002/ccd.21748

M3 - Article

C2 - 19021287

AN - SCOPUS:60749129573

VL - 72

SP - 988

EP - 993

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

SN - 1522-1946

IS - 7

ER -